Elevance Health, Inc. (FRA:A58)

Elevance Health Statistics

Total Valuation

Elevance Health has a market cap or net worth of EUR 66.07 billion. The enterprise value is 86.32 billion.

Market Cap	66.07B
Enterprise Value	86.32B

Important Dates

The last earnings date was Wednesday, October 15, 2025.

Earnings Date	Oct 15, 2025
Ex-Dividend Date	Sep 10, 2025

Share Statistics

Current Share Class	223.24M
Shares Outstanding	n/a
Shares Change (YoY)	-3.08%
Shares Change (QoQ)	-0.93%
Owned by Insiders (%)	0.13%
Owned by Institutions (%)	94.78%
Float	222.72M

Valuation Ratios

The trailing PE ratio is 14.01 and the forward PE ratio is 12.52.

PE Ratio	14.01
Forward PE	12.52
PS Ratio	0.40
PB Ratio	1.76
P/TBV Ratio	18.57
P/FCF Ratio	20.58
P/OCF Ratio	15.78
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.00, with an EV/FCF ratio of 26.89.

EV / Earnings	18.31
EV / Sales	0.51
EV / EBITDA	11.00
EV / EBIT	12.34
EV / FCF	26.89

Financial Position

The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.73.

Current Ratio	1.56
Quick Ratio	1.43
Debt / Equity	0.73
Debt / EBITDA	3.52
Debt / FCF	8.52
Interest Coverage	5.90

Financial Efficiency

Return on equity (ROE) is 12.57% and return on invested capital (ROIC) is 6.89%.

Return on Equity (ROE)	12.57%
Return on Assets (ROA)	4.24%
Return on Invested Capital (ROIC)	6.89%
Return on Capital Employed (ROCE)	9.92%
Revenue Per Employee	1.59M
Profits Per Employee	45,257
Employee Count	104,200
Asset Turnover	1.63
Inventory Turnover	n/a

Taxes

In the past 12 months, Elevance Health has paid 1.34 billion in taxes.

Income Tax	1.34B
Effective Tax Rate	22.15%

Stock Price Statistics

The stock price has decreased by -24.58% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-24.58%
50-Day Moving Average	277.49
200-Day Moving Average	328.03
Relative Strength Index (RSI)	56.24
Average Volume (20 Days)	176

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.46

Income Statement

In the last 12 months, Elevance Health had revenue of EUR 166.05 billion and earned 4.72 billion in profits. Earnings per share was 20.78.

Revenue	166.05B
Gross Profit	43.61B
Operating Income	6.92B
Pretax Income	6.05B
Net Income	4.72B
EBITDA	7.61B
EBIT	6.92B
Earnings Per Share (EPS)	20.78

Balance Sheet

The company has 30.87 billion in cash and 27.36 billion in debt, giving a net cash position of -19.93 billion.

Cash & Cash Equivalents	30.87B
Total Debt	27.36B
Net Cash	-19.93B
Net Cash Per Share	n/a
Equity (Book Value)	37.57B
Book Value Per Share	168.72
Working Capital	19.52B

Cash Flow

In the last 12 months, operating cash flow was 4.19 billion and capital expenditures -975.88 million, giving a free cash flow of 3.21 billion.

Operating Cash Flow	4.19B
Capital Expenditures	-975.88M
Free Cash Flow	3.21B
FCF Per Share	n/a

Margins

Gross margin is 26.26%, with operating and profit margins of 4.17% and 2.84%.

Gross Margin	26.26%
Operating Margin	4.17%
Pretax Margin	3.64%
Profit Margin	2.84%
EBITDA Margin	4.58%
EBIT Margin	4.17%
FCF Margin	1.93%

Dividends & Yields

This stock pays an annual dividend of 6.08, which amounts to a dividend yield of 2.04%.

Dividend Per Share	6.08
Dividend Yield	2.04%
Dividend Growth (YoY)	3.98%
Years of Dividend Growth	6
Payout Ratio	27.56%
Buyback Yield	3.08%
Shareholder Yield	5.11%
Earnings Yield	7.14%
FCF Yield	4.86%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5